clavicle fracture
Conditions
Interventions
Control group (Group C):The control group have no intervention
Dexmedetomidine intravenous infusion group (Group IN):Intravenous infusion of dexmedetomidine
Dexmedetomidine perineuronal injection group (Group PN):Perineuronal injection of dexmedetomidine
Sponsors
Ningbo Medical Centre Lihuili Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed with clavicle fracture by X-ray, B-ultrasound and other imaging or who intend to undergo clavicle surgery for other reasons; 2.Age 18~65 years old, and BMI<=30Kg/m^2; 3.ASAI.~II., NYHA cardiac function grade I.~II.; 4.Sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1.Serious heart and lung disease or liver and kidney insufficiency; 2. Patients with a history of severe infection at the puncture site; 3 Abnormal coagulation function; 4. People with a history of local anesthetic allergy or dexmedetomidine contraindication; 5. Mental disorders and language communication disorders; 6. concurrent fractures or injuries in other parts; 7. Users of long-acting opioids; 8.Refusal of cervical and brachial plexus block or refusal to sign informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Perioperative vital signs of clavicular fracture; | — |
Secondary
| Measure | Time frame |
|---|---|
| Perioperative adverse events; | — |
Countries
China
Contacts
Public ContactMa Junmei
Ningbo Medical Centre Lihuili Hospital
Outcome results
None listed